These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 22735681)

  • 1. Inhibition of cannabinoid CB1 receptor upregulates Slc2a4 expression via nuclear factor-κB and sterol regulatory element-binding protein-1 in adipocytes.
    Furuya DT; Poletto AC; Freitas HS; Machado UF
    J Mol Endocrinol; 2012 Oct; 49(2):97-106. PubMed ID: 22735681
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Estrogen receptor 1 agonist PPT stimulates Slc2a4 gene expression and improves insulin-induced glucose uptake in adipocytes.
    Campello RS; Alves-Wagner AB; Lucas TF; Mori RC; Furuya DT; Porto CS; Machado UF
    Curr Top Med Chem; 2012; 12(19):2059-69. PubMed ID: 23167795
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulation of GLUT4 gene expression by SREBP-1c in adipocytes.
    Im SS; Kwon SK; Kang SY; Kim TH; Kim HI; Hur MW; Kim KS; Ahn YH
    Biochem J; 2006 Oct; 399(1):131-9. PubMed ID: 16787385
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The CB1 endocannabinoid system modulates adipocyte insulin sensitivity.
    Motaghedi R; McGraw TE
    Obesity (Silver Spring); 2008 Aug; 16(8):1727-34. PubMed ID: 18551116
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insulin acutely triggers transcription of Slc2a4 gene: participation of the AT-rich, E-box and NFKB-binding sites.
    Moraes PA; Yonamine CY; Pinto Junior DC; Esteves JV; Machado UF; Mori RC
    Life Sci; 2014 Sep; 114(1):36-44. PubMed ID: 25123536
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nuclear Factor-Kappa-B Mediates the Advanced Glycation End Product-Induced Repression of
    Michalani MLE; Passarelli M; Machado UF
    Int J Mol Sci; 2024 Jul; 25(15):. PubMed ID: 39125811
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of nuclear factor-κB sites in the Slc2a4 gene promoter.
    Furuya DT; Neri EA; Poletto AC; Anhê GF; Freitas HS; Campello RS; Rebouças NA; Machado UF
    Mol Cell Endocrinol; 2013 May; 370(1-2):87-95. PubMed ID: 23462193
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oleic and linoleic fatty acids downregulate Slc2a4/GLUT4 expression via NFKB and SREBP1 in skeletal muscle cells.
    Poletto AC; Furuya DT; David-Silva A; Ebersbach-Silva P; Santos CL; Corrêa-Giannella ML; Passarelli M; Machado UF
    Mol Cell Endocrinol; 2015 Feb; 401():65-72. PubMed ID: 25486510
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Estradiol stimulates adipogenesis and Slc2a4/GLUT4 expression via ESR1-mediated activation of CEBPA.
    Fatima LA; Campello RS; Barreto-Andrade JN; Passarelli M; Santos RS; Clegg DJ; Machado UF
    Mol Cell Endocrinol; 2019 Dec; 498():110447. PubMed ID: 31100494
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Estradiol-induced regulation of GLUT4 in 3T3-L1 cells: involvement of ESR1 and AKT activation.
    Campello RS; Fátima LA; Barreto-Andrade JN; Lucas TF; Mori RC; Porto CS; Machado UF
    J Mol Endocrinol; 2017 Oct; 59(3):257-268. PubMed ID: 28729437
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genome-wide expression profiling revealed peripheral effects of cannabinoid receptor 1 inverse agonists in improving insulin sensitivity and metabolic parameters.
    Zhao W; Fong O; Muise ES; Thompson JR; Weingarth D; Qian S; Fong TM
    Mol Pharmacol; 2010 Sep; 78(3):350-9. PubMed ID: 20530130
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activation of cannabinoid CB1 receptors induces glucose intolerance in rats.
    Bermúdez-Siva FJ; Serrano A; Diaz-Molina FJ; Sánchez Vera I; Juan-Pico P; Nadal A; Fuentes E; Rodríguez de Fonseca F
    Eur J Pharmacol; 2006 Feb; 531(1-3):282-4. PubMed ID: 16423347
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Blockade of cannabinoid receptor 1 improves insulin resistance, lipid metabolism, and diabetic nephropathy in db/db mice.
    Nam DH; Lee MH; Kim JE; Song HK; Kang YS; Lee JE; Kim HW; Cha JJ; Hyun YY; Kim SH; Han SY; Han KH; Han JY; Cha DR
    Endocrinology; 2012 Mar; 153(3):1387-96. PubMed ID: 22234468
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Estrogen Receptor 1 (ESR1) Enhances
    Barreto-Andrade JN; de Fátima LA; Campello RS; Guedes JAC; de Freitas HS; Machado MMOUF
    Int J Med Sci; 2018; 15(12):1320-1328. PubMed ID: 30275758
    [No Abstract]   [Full Text] [Related]  

  • 15. Endocannabinoids regulate adipokine production and the immune balance of omental adipose tissue in human obesity.
    Ge Q; Maury E; Rycken L; Gérard J; Noël L; Detry R; Navez B; Brichard SM
    Int J Obes (Lond); 2013 Jun; 37(6):874-80. PubMed ID: 22868830
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Paracrine activation of hepatic CB1 receptors by stellate cell-derived endocannabinoids mediates alcoholic fatty liver.
    Jeong WI; Osei-Hyiaman D; Park O; Liu J; Bátkai S; Mukhopadhyay P; Horiguchi N; Harvey-White J; Marsicano G; Lutz B; Gao B; Kunos G
    Cell Metab; 2008 Mar; 7(3):227-35. PubMed ID: 18316028
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cannabinoid CB
    Chen W; Liu H; Guan H; Xue N; Wang L
    Eur J Pharmacol; 2017 Nov; 814():232-239. PubMed ID: 28844874
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antidiabetic effects of sub-chronic administration of the cannabinoid receptor (CB1) antagonist, AM251, in obese diabetic (ob/ob) mice.
    Irwin N; Hunter K; Frizzell N; Flatt PR
    Eur J Pharmacol; 2008 Feb; 581(1-2):226-33. PubMed ID: 18191122
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Peripherally acting CB1-receptor antagonist: the relative importance of central and peripheral CB1 receptors in adiposity control.
    Son MH; Kim HD; Chae YN; Kim MK; Shin CY; Ahn GJ; Choi SH; Yang EK; Park KJ; Chae HW; Moon HS; Kim SH; Shin YG; Yoon SH
    Int J Obes (Lond); 2010 Mar; 34(3):547-56. PubMed ID: 20029379
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sympathetic Regulation of Slc2a4 Gene Expression: Participation of a Putative cAMP Responsive Element (CRE) Site in the Slc2a4 Promoter.
    Alves-Wagner AB; Yonamine CY; de Fatima LA; Festuccia W; Machado UF
    Cell Physiol Biochem; 2019; 52(3):580-594. PubMed ID: 30897323
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.